It has been shown recently that CDK9 phosphorylated METTL3 and regulated its nuclear/cytosolic translocation in NASH livers34, which indicates that CDK9 may also regulate WTAP. This evidence concerns the gene CDK9 and metabolic dysfunction-associated steatohepatitis.